» Capital Raising for Raval Pharmaceuticals

Infra Financials is pleased to announce its appointment as the Mandated Lead Arranger (MLA) by Raval Pharmaceutical Manufacturing Plc. for the arrangement and structuring of capital amounting to USD 14M.

Raval Pharma is constructing an intravenous fluid manufacturing plant in the northern, vibrant city of Debre Berhan, Ethiopia.

Accordingly, the new facility will be situated on 50,000m2 of land in a prime location of Debre Berhan town. Equipped with the latest and advanced technologies to produce high-quality pharmaceutical products, Raval Pharma plans to manufacture various volumes of LVP and SVP IV Solutions to meet the overwhelming demand in Ethiopia.

The agreement was signed by Infra Financials and Kishen Raval Esq. Managing Director of Raval Pharmaceutical on November 28, 2019.

For more information contact:
Corporate Communication Officer-Infra Group
Email: pr@infragroup.net